Rehovot, Israel

Irun R Cohen

This inventor holds 71 USPTO granted patents and 24 published patent applications, plus 4 CIPO patents and 18 EPO patents, primarily in Autoimmune Disease Diagnosis (CPC class A61K). Top assignees: Yeda Research and Develpment & Co. Ltd, Alma Bio Therapeutics, Stem Cell Medicine Ltd.. Active years: 1983-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irun R Cohen. Retrieved from https://idiyas.com/inventor/irun-r-cohen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 71 

% Patents Active = 67.6

 

 

Average Co-Inventor Count = 3.6

ph-index = 15

Forward Citations = 702(Granted Patents)

Forward Citations (Not Self Cited) = 611(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Reheovot, IL (1989)
  • Rehovet, IL (1993)
  • Herzliya, IL (1995)
  • Rechovot, IL (2011)
  • Rehovot, IL (US) (2014)
  • Rehovot, IL (1983 - 2024)

Company Filing History:

goldMedal60 out of 1,168 
 
Yeda Research and Develpment & Co. Ltd
 patents
silverMedal3 out of 3 
 
Alma Bio Therapeutics
 patents
bronzeMedal2 out of 6 
 
Stem Cell Medicine Ltd.
 patents
4. 2 out of 13 
 
Universitatsklinikum Hamburg-Eppendorf
 patents
5. 1 out of 34 
 
B.g. Negev Technologies and Applications Ltd.
 patents
6. 1 out of 364 
 
Ben-Gurion University of the Negev Research and Development Authority
 patents
7. 1 out of 1 
 
De Staat Der Nederlanden Vertegenwoordigd Voor De Minister Van Welzijn,
 patent
8. 1 out of 4 
 
De Staat Der Nederlanden, Vertegenwoordigd Door De Minister Van Welzijn,
 patents
9. 1 out of 1 
 
Hadasit Medical Research Services and Dev. Ltd
 patent
10. 1 out of 1 
 
Hadassa Medical Organization
 patent
11. 1 out of 1 
 
Immunarray Ltd.
 patent
12. 1 out of 105 
 
Mor Research Applications Ltd.
 patents
13. 1 out of 1 
 
Rijksuniversiteit Te Utrecht
 patent
14. 1 out of 1 
 
Riksuniversiteit Te Utrecht
 patent
15. 1 out of 1,425 
 
The Brigham and Women's Hospital, Inc.
 patents
16. 1 out of 60 
 
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center
 patents
17. 1 out of 49 
 
The Weizmann Institute of Science
 patents
18. 1 out of 1 
 
Yeda Research & Dev., Co., Ltd.
 patent
19. 4 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1983-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Autoimmune Disease
Neurodegenerative Diseases
Biomarkers
DNA Vaccines
HSP60 Peptides
Cancer Diagnosis
T Cell Immunomodulation
Peptide Inhibitors
Cytokine Regulation
Alzheimer's Disease
Systemic Lupus Erythematosus
Multiple Sclerosis
71 patents (USPTO):Explore Patents

Title: The Innovative Mind of Irun R Cohen

Introduction: Irun R Cohen is a distinguished inventor hailing from Rehovot, Israel. His groundbreaking work has significantly impacted the field of innovation and patents.

Latest Patents: Cohen's latest patents showcase his continuous dedication to pushing the boundaries of technology and science, with a focus on improving the lives of people globally.

Career Highlights: Throughout his illustrious career, Cohen has been at the forefront of numerous technological advancements. His contributions have earned him a reputation as a visionary in the world of inventions.

Collaborations: Cohen has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His ability to work with diverse teams has led to the development of revolutionary products.

Conclusion: In conclusion, Irun R Cohen's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His work continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…